Man Infra Q1 FY27: PAT up 29% YoY at Rs 71.6 cr, board changes

Pat Growth 25pctResults RestatedResults View source PDF Explain this filing

MANINFRA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.0%Reaction day

₹111.10

prior close

₹113.99

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-3.4% vs market

Residential Commercial Projects peers, median of 64sector-0.9%-2.1% vs sector

On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250 and 2.1 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.1

10m

-0.0

15m

-0.4

30m

-2.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.0+0.4-3.4-0.9-2.1

Next day

-5.7+0.5-6.2-0.3-5.4

-4.4+0.6-5.0-0.1-4.3

-6.4+0.7-7.1+0.8-7.2

-4.2+1.1-5.3-0.3-3.8

-1.1+0.5-1.6-1.6+0.5

-2.3+1.3-3.6-0.3-2.0

15d

+10.5+0.5+10.0-3.5+14.1

+11.7-0.8+12.5-7.4+19.1

+4.1-0.9+5.1-8.2+12.3

—————

UpDownMarket · Nifty Microcap 250Sector · Residential Commercial Projects peers, median of 64Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated Q1 revenue Rs 218.31 cr vs Rs 202.85 cr YoY. PAT up 29% at Rs 71.64 cr vs Rs 55.57 cr. EPS Rs 1.77 vs Rs 1.48. Real estate segment revenue Rs 136.78 cr vs Rs 101.40 cr. Interest income reclassified as operating revenue, prior periods restated. Board appointed Vatsal Shah as Non-Executive Director and S. Iyer as Independent Director; Parag Shah re-designated as Chairman. Approvals pending via postal ballot.

Likely market impact

Strong profit growth led by real estate segment. Promoter's son joins board; new appointments need shareholder approval via postal ballot.